Pandorum - About the company
Pandorum is a series B company based in Bengaluru (India), founded in 2011 by Tuhin Bhowmick and Arun Chandru. It operates as a Developer of regenerative medicine and 3D tissues. Pandorum has raised $52.1M in funding from investors like BTB Venture, Indian Angel Network and PROTONS CORPORATE SERVICES, with a current valuation of $*****. The company has 591 active competitors, including 182 funded and 96 that have exited. Its top competitors include companies like MedGenome, Biocytogen and Caris Life Sciences.
Company Details
Developer of regenerative medicine and 3D tissues. It has developed a working 3D tissue through 3D printing and fabrication techniques. The products include bioengineered cornea which is a hydrogel formulation used for blindness, 3D hepatocyte spheroids for drug discovery and liver therapies, and exosome cell-free therapy for lung regeneration.
- Website
- pandorum.com
- Social
- Email ID
- *****@pandorumtechnologies.in
- Phone Number
- +91 **********
- Registered Address
- EGF 4 & 5, Bangalore Bioinnovation Centre, Helix Biotech Park, Electronic City Phas, e 1, Bangalore, Bengaluru, Karnataka, India, 560100
Key Metrics
Founded Year
2011
Location
Bengaluru, India
Stage
Series B
Total Funding
$52.1M in 13 rounds
Latest Funding Round
Post Money Valuation
$***** as on Mar 30, 2026
Investors
Ranked
4th among 591 active competitors
Annual Revenue
0 - ₹10 Cr as on Mar 31, 2025
Employee Count
28 as on Aug 31, 2025
Legal entities associated with Pandorum
Pandorum is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
PANDORUM TECHNOLOGIES PRIVATE LIMITED CIN: U72200KA2011PTC058650 , India, Active | May 16, 2011 | 0 - ₹10 Cr (As on Mar 31, 2025) | 28 (As on Aug 01, 2025) |
Sign up to download Pandorum's company profile
Pandorum's funding and investors
Pandorum has raised a total funding of $52.1M over 13 rounds. Its first funding round was on 2012. Its latest funding round was a Series B round on Mar 20, 2026 for $*****. 1 investor participated in its latest round. Pandorum has 35 institutional investors and 56 angel investors.
Here is the list of recent funding rounds of Pandorum:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Mar 20, 2026 | 8327946 | Series B | 6121112 | 7789861 | 5623490 | 6806482 |
Jan 16, 2026 | 9718214 | Series B | 4980976 | 4427758 | 8449111 | |
Oct 24, 2025 | 3821348 | Series B | 2674168 | 2602307 |
Access funding benchmarks and valuations. Sign up today!View details of Pandorum's funding rounds and investors
Pandorum's founders and board of directors
Founder? Claim ProfileThe founders of Pandorum are Tuhin Bhowmick and Arun Chandru. Tuhin Bhowmick is the CEO of Pandorum.
Here are the details of Pandorum's key team members:
- Tuhin Bhowmick: Co-Founder & CEO & Director of Pandorum and founder of 1 other company. They serve on the board of 1 company.Contact Info: 1 email address and 1 phone number
- Arun Chandru: Co-Founder& CTO & Director of Pandorum and founder of 2 other companies, Pandorum Technologies and Pandorum Technologies. They serve on the board of 1 company.Contact Info: 1 email address and 1 phone number
Pandorum's Board of Directors
Pandorum's board has 5 active members. Tuhin Bhowmick and Arun Chandru are part of team and Sailesh Tulshan, Sudipta Gautam and Sonal Asthana are independent board members.Here is the list of Pandorum's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 15y 4m | |
Team | - | Current | 15y 4m | |
Independent board member | - | Current | 8y 1m | |
trppapx | Independent board member | - | Current | 6y 1m |
mzgsmxh | Independent board member | - | Past | 9y 7m |
tosfjfm | Independent board member | - | Past | 6y 2m |
View details of Pandorum's Founder profiles and Board Members
Pandorum's employee count trend
Pandorum has 28 employees as of Aug 25. The total employee count is 8.0% more than what it was in Aug 24. Here is Pandorum's employee count trend over the years:
Uncover Pandorum's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Pandorum's Competitors and alternates
Top competitors of Pandorum include MedGenome, Biocytogen and Caris Life Sciences. Here is the list of Top 10 competitors of Pandorum, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Provider of DNA sequencing, bioinformatics, and multiomics services | $264M | 70/100 | ||
2nd | Biocytogen 2008, Wakefield (United States), Public | Provider of integrated solutions for next-generation antibody drug development | $301M | 67/100 | |
3rd | Caris Life Sciences 1996, Irving (United States), Public | Developer of panomic disease profiling technologies for cancer precision medicine | $1.23B | 66/100 | |
4th | Developer of regenerative medicine and 3D tissues | $52.1M | 65/100 | ||
5th | Aspen Neuroscience 2018, San Diego (United States), Series C | Provider of genomic-based personalised pluripotent stem cell therapy | $339M | 65/100 | |
6th |  InSphero 2009, Schlieren (Switzerland), Series D | Developer of cell based assays for drug screening | $35M | 62/100 | |
7th | Blue Rock Therapeutics 2016, Boston (United States), Acquired | Stem cell therapies for cardiovascular and neurological diseases | $225M | 62/100 | |
8th |  UniQure 1998, Amsterdam (Netherlands), Public | Developer of gene-based therapies for patients with genetic or acquired diseases | $111M | 62/100 | |
9th | Ncardia 2011, The Hague (Netherlands), Series C | Company offering hiPSC based products and services for drug discovery and development | $77.4M | 61/100 | |
10th | Personalis 2011, Menlo Park (United States), Acquired | Provider of genomic sequencing and diagnosis software for the healthcare industry | $87.3M | 61/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Pandorum's competitors? Click here to see the top ones
Pandorum's Latest cap tables and shareholding
Founders own 23.39%, Funds own 19.08%, Enterprises own 22.35% and Angels (largest shareholder) own 24.48%. The net worth of Pandorum's founders is INR 192Cr as of Mar 30, 2026.
Shareholders Name | Post Round Holding % | Net worth | Cumulative Investment | Realised Returns | Unrealised Returns | Return Multiple |
|---|---|---|---|---|---|---|
Founder | 23.39% | 192Cr | 7261452 | 3633242 | 3797742 | 3540897 |
5755705 | 7577338 | 4603533 | 6621364 | 1051709 | 9712081 | |
7261191 | 3353696 | 4518018 | 7130351 | 3445493 | 9229725 | |
Fund | 19.08% | 157Cr | 8079619 | 1676269 | 3562727 | 8733876 |
0 | 0 | 0 | 0 | 0 | 0 | |
Enterprise | 22.35% | 184Cr | 7287665 | 8139718 | 2647624 | 3332167 |
Angel | 24.48% | 201Cr | 8421212 | 8249240 | 1312972 | 7927090 |
Other People | 4.66% | 38.3Cr | 2082 | 3715 | 8075 | 6692 |
ESOP Pool | 6.04% | 49.6Cr | 515655 | 612519 | 506891 | 648847 |
Total | 100.00% | 821Cr | 6176225 | 7286790 | 5942308 | 3392750 |
To unlock detailed Cap Table of Pandorum Sign up today!Notes: The column Net Worth represents the net worth of investments made by that entity, as per the latest cap table.
DisclaimerView more details of Pandorum's Shareholding
Pandorum's Investments and acquisitions
Pandorum has made no investments or acquisitions yet.
Reports related to Pandorum
Here is the latest report on Pandorum's geography:
News related to Pandorum
Filter this listMedia has covered Pandorum for a total of 4 events in the last 1 year, 1 of them has been about partnerships.
•
Indian biotech startup Pandorum Technologies raises $18 million in fundingIndian Startup News•Feb 09, 2026•Galentic Pharma, Pandorum, Avinya Ventures
•
•
Pandorum Technologies to receive funding of $8 million in Series B, led by Trufort Fund LimitedEntrackr•Dec 19, 2025•Pandorum
•
•
Biotech startup Immuneel Therapeutics raised Rs 100 Cr in extended Series A roundIncubees•Jul 10, 2024•Immuneel, Eight Roads Ventures, True North, F-Prime Capital and 4 others
•
•
Biotech Startup Pandorum To Raise $8 Mn From Ashish Kacholia, Everest FinanceInc42•Feb 07, 2024•Pandorum, Everest
•
Pandorum Technologies launches Centre to offer regenerative therapy for corneal blindnessBioSpectrum India•Jun 14, 2023•Pandorum, Shroff Eye Centre
•
•
New partnership set to use AI to accelerate regenerative medicineLongevity.Technology•Mar 14, 2022•Pandorum, Wipro
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Pandorum
Explore our recently published companies
- Funalux - Belgium based, Unfunded company
- MemoApp PH - Philippines based, Unfunded company
- ASK.BI - Slovenia based, Unfunded company
- VDM (Valuechain Digital Management) - Cyprus based, 2023 founded, Unfunded company
- Relimit - Kreuzau based, 2015 founded, Unfunded company
- MSL Web - Stockport based, 2007 founded, Unfunded company
